Nimish P. Shah, Director at Apogee Therapeutics, Inc. (APGE), bought 1,750,000 shares at $17.00 ($29.8M) on 2023-07-13, disclosed to the SEC on 2023-07-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| TCDA | BUY | 2022-10-17 | $4.1M | — | Filing → |
| TCDA | BUY | 2022-10-11 | $2.6M | — | Filing → |
| TIL | BUY | 2021-03-25 | $6.0M | — | Filing → |